Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenovirus receptors and entry factors are a diverse group of cell surface molecules that facilitate the attachment and internalization of adenoviruses into host cells. The primary attachment receptor for many common serotypes, such as Ad5, is the Coxsackievirus and adenovirus receptor (CAR), a member of the immunoglobulin superfamily (Bergelson et al., 1997, Science). Other serotypes, particularly those in Group B, utilize CD46 or Desmoglein-2 (DSG2) as their primary docking sites (Gaggar et al., 2003, Nature Medicine; Wang et al., 2011, Nature Medicine). Following initial attachment, the virus typically interacts with secondary entry factors, most notably alpha-v integrins (e.g., alpha-v beta-3 and alpha-v beta-5), which recognize the RGD motif in the viral penton base and trigger clathrin-mediated endocytosis (Wickham et al., 1993, Cell). In oncology, the expression levels of these receptors on tumor cells are critical determinants of the efficacy of oncolytic adenoviruses and viral-mediated gene therapies. However, therapeutic challenges remain, including the downregulation of CAR in advanced tumors and the high sequestration of viral vectors in the liver through interactions between the viral hexon and blood coagulation Factor X (Waddington et al., 2008, Cell).
Facilitation of viral attachment to the cell surface followed by secondary interaction with entry factors to trigger endocytosis and intracellular trafficking.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenovirus receptors and entry factors.